Emclaire Financial Corp - Condensed Financial Statements, Parent Corporation Only (Tables)

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Schedule of Condensed Balance Sheet

Following are condensed financial statements for the parent company as of and for the years ended December 31: 

Condensed Balance Sheets
(Dollar amounts in thousands)	2016		2015
Assets:
Cash and cash equivalents	$	20	$	107
Securities available for sale	2,056		1,834
Equity in net assets of subsidiaries	59,078		51,209
Other assets	982		848
Total Assets	$	62,136	$	53,998
Liabilities and Stockholders' Equity:
Short-term borrowed funds with affiliated subsidiary bank	$	1,000	$	1,000
Other short-term borrowed funds	2,500		—
Long-term borrowed funds	4,500		—
Accrued expenses and other liabilities	63		159
Stockholders' equity	54,073		52,839
Total Liabilities and Stockholders' Equity	$	62,136	$	53,998

Schedule of Condensed Income Statement

Condensed Statements of Income
(Dollar amounts in thousands)	2016		2015
Income:
Dividends from subsidiaries	$	3,132	$	2,731
Investment income	66		376
Total income	3,198		3,107
Expense:
Interest expense	265		111
Noninterest expense	392		667
Total expense	657		778
Income before income taxes and undistributed subsidiary income	2,541		2,329
Undistributed equity in net income of subsidiary	1,244		1,688
Net income before income taxes	3,785		4,017
Income tax benefit	201		137
Net income	$	3,986	$	4,154
Comprehensive income	$	3,257	$	3,390

Schedule of Condensed Cash Flow Statement

Condensed Statements of Cash Flows
(Dollar amounts in thousands)	2016			2015
Operating activities:
Net income	$	3,986		$	4,154
Adjustments to reconcile net income to net cash provided by operating activities:
Undistributed equity in net income of subsidiary	(1,244		)	(1,688		)
Realized gains on sales of available for sale securities, net	—			(298		)
Other, net	(101		)	134
Net cash provided by operating activities	2,641			2,302
Investing activities:
Sales (purchases) of investment securities	—			885
Investment in subsidiaries	(7,500		)	(1,000		)
Net cash used in investing activities	(7,500		)	(115		)
Financing activities:
Net change in borrowings	7,000			(3,375		)
Proceeds from issuance of common stock	4			8,151
Redemption of preferred stock (Series B)	—			(5,000		)
Proceeds from exercise of stock options, including tax benefit	—			81
Dividends paid	(2,232		)	(1,957		)
Net cash provided by (used in) financing activities	4,772			(2,100		)
Increase (decrease) in cash and cash equivalents	(87		)	87
Cash and cash equivalents at beginning of period	107			20
Cash and cash equivalents at end of period	$	20		$	107